This guidance follows the FDAs approval of Wegovy (semaglutide) for an expanded indication to reduce the risk of major cardiovascular events (MACE), including cardiovascular death, non-fatal myocardial infarction, and non-fatal stroke in adults with established cardiovascular disease (CVD) and who are either obese or overweight
While GLP-1 drugs are not approved as addiction treatments, these observed side effects could boost the economy and workforce, Barro wrote
This dramatic decline with age corresponds with many of the changes we associate with aging, particularly in skin and hair
And dumping syndrome can develop years after surgery
Trials should stratify participants by hormone formulation, route of delivery, baseline metabolic health, and time since menopause